source
- Argenx halts late-stage Vyvgart trial in Sjogren’s disease after futility finding, shares tumble 13%Argenx announced it is ending the Phase 3 UNITY trial of its Vyvgart Hytrulo injection in Sjogren’s disease after an independent data monitoring committee concluded the study would not meet its pri…
- Newron reports five deaths in schizophrenia trial as FDA keeps hold on evenamide studyNewron Pharmaceuticals disclosed that five participants have died in its late-stage schizophrenia trial, with four deaths among those receiving the investigational drug evenamide and one death amon…